No Data
No Data
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
Omeros Establishes Oncology Clinical Steering Committee Of Leading AML Experts From Top Cancer Centers To Advance Its OncotoX Biologics Program Targeting High-Unmet-Need Acute Myeloid Leukemia With Proprietary Engineered Molecules Designed To Deliver...
Express News | Omeros Announces the Omeros Oncology Clinical Steering Committee for Aml to Help Guide Omeros’ Proprietary Oncotox-Aml Clinical Program
Needham Maintains Omeros(OMER.US) With Hold Rating
Omeros Corporation's Earnings Call Highlights Progress and Challenges
Needham Reiterates Hold on Omerosto Hold